Hamilton Thorne Ltd. (CVE:HTL – Get Free Report) was up 4.3% during mid-day trading on Tuesday. The company traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares were traded during trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Trading Up 4.3%
The company has a market capitalization of C$149.69 million, a PE ratio of 58.94 and a beta of 0.54. The company’s fifty day moving average is C$1.45 and its 200-day moving average is C$1.45. The company has a debt-to-equity ratio of 43.24, a current ratio of 2.04 and a quick ratio of 2.25.
About Hamilton Thorne
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
See Also
- Five stocks we like better than Hamilton Thorne
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
